Levosimendan improves cardiopulmonary resuscitation and survival by K(ATP) channel activation.
Cammarata
Gianluca A A M
GA
Weil
Max Harry
MH
Sun
Shijie
S
Huang
Lei
L
Fang
Xiangshao
X
Tang
Wanchun
W
D000255:Adenosine Triphosphate; D000818:Animals; D016887:Cardiopulmonary Resuscitation; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D006835:Hydrazones / Q000627:therapeutic use*; D008297:Male; D009203:Myocardial Infarction / Q000401:mortality / Q000628:therapy*; D015221:Potassium Channels / Q000187:drug effects*; D011724:Pyridazines / Q000627:therapeutic use*; D051381:Rats; D017207:Rats, Sprague-Dawley; D000077464:Simendan; D015996:Survival Rate
D002316:Cardiotonic Agents; D006835:Hydrazones; D015221:Potassium Channels; D011724:Pyridazines; D000077464:Simendan; D000255:Adenosine Triphosphate